Revised: Nicorandil for Injection Market Analysis 2023: Industry Share, Growth Outlook, Top Companies – Actiza Pharmaceutical, Taj…
Introduction
Nicorandil is a medication that widens blood vessels and allows for easier blood flow to vital organs and tissues of the body. Nicorandil is administered through injection and is commonly used to treat angina pectoris or chest pain. According to a recent market analysis, the Nicorandil for Injection market is expected to grow significantly in the next few years.
Market Overview
The Nicorandil for Injection market is expected to grow at a CAGR of 4.2% during the forecast period of 2018 to 2023. The market is estimated to be worth $73 million by 2023. The growth of the market can be attributed to the increasing prevalence of angina pectoris coupled with the rising geriatric population across the globe. Additionally, the growing demand for better healthcare facilities and the advancements in technology are further expected to fuel market growth.
Top Companies in the Market
The Nicorandil for Injection market is highly fragmented with several key players dominating the market. Some of the top companies in the market include Actiza Pharmaceutical, Taj Pharmaceuticals, Afford Medicines, Bell Pharma, and others.
Regional Analysis
North America dominates the Nicorandil for Injection market due to the high prevalence of angina pectoris and a well-established healthcare infrastructure. Europe is expected to be the second largest market for Nicorandil for Injection due to the increasing geriatric population and rising demand for better healthcare facilities. The Asia Pacific region is expected to witness significant growth during the forecast period due to the increasing disposable income, growing healthcare sector, and rising awareness regarding heart diseases.
Conclusion
The Nicorandil for Injection market is projected to experience significant growth in the next few years. The growing prevalence of angina pectoris and the rising geriatric population are some of the key factors driving market growth. Additionally, the increasing demand for better healthcare facilities and advancements in technology are expected to further boost market growth.
#NicorandilInjection #AnginaPectoris #MarketAnalysis #TopCompanies #ActizaPharmaceutical #TajPharmaceuticals #AffordMedicines #BellPharma #HealthcareSector #GlobalMarket #IndustryTrends
Summary:
The Nicorandil for Injection market is expected to witness significant growth in the coming years, driven by factors such as the rising prevalence of angina pectoris and the increasing geriatric population across the globe. North America currently dominates the market, while the Asia Pacific region is expected to witness significant growth in the coming years. Some of the top companies in the market include Actiza Pharmaceutical, Taj Pharmaceuticals, Afford Medicines, and Bell Pharma. #BUSINESS